Searched for
INDIA PHARMACEUTICAL SECTOR
India, Uzbekistan could explore FTA, says Piyush Goyal; Uzbekistan invites Indian investment in mining, rare earthsIndia and Uzbekistan aim to double bilateral trade to three billion dollars within three years. Businesses are urged to increase investment...
Hyderabad airport enhances Taipei-Hyd-Dubai cargo corridor with Emirates SkyCargo OpsHyderabad Airport recently celebrated the launch of Emirates SkyCargo's new Boeing 777 Freighter service, which establishes a vital connect...
India's exports from SEZs up 11.8% in 2025-26: GovtExports from special economic zones experienced a remarkable boost in 2025-26, eclipsing USD 185 billion. The pharmaceutical industry also ...
Saudi Aramco supplier HD Fire plans to launch IPO in OctoberFire protection systems manufacturer HD Fire Protect is planning to launch its IPO in October through an offer for sale of 2.6 crore shares...
Quant MF ups IT exposure as sector enters ‘neglected territory’; sees crude correctionQuant Mutual Fund has raised its exposure to IT services over the past two months, viewing the sector as increasingly “neglected” and offer...
India pharma sector to miss 2030 sales target amid tariff and shipping woes, trade body saysIndia's pharmaceutical industry is expected to reach$80-90 billion by 2030, well below its earlier$130 billion target, as U.S. tariff uncer...
Government invites applications for 30 products' import quota under India-Oman trade pactUnder the CEPA, India has granted quota-based tariff concessions to certain Omani goods such as dates, marble, copper weld wire, aluminium ...
ITC's Sanjiv Puri says CPP acquisition marks 'defining milestone' for paper businessIn a social media post, Puri welcomed the CPP workforce to ITC, saying the integration brings together two enterprises with a shared commit...
India-Arab business chambers join hands to push trade & investment tiesIndia and Arab countries signed a trade and investment pact this week. The agreement aims to boost bilateral trade and business partnership...
Sankaran Naren favours banks, power as oil risks loomSankaran Naren, CIO of ICICI Prudential Asset Management, remains bullish on banks, power utilities, oil refiners and pharmaceuticals, citi...
ChrysCapital acquires controlling 70.68% stake in Novartis India listed unit in first majority pharma investmentChrysCapital has acquired a controlling interest in Novartis India Limited, representing its inaugural investment in India's pharmaceutical...
India’s merchandise exports to new FTA partners are expected to reach $1 trillion by 2035: ASSOCHAMThe new wave of India’s FTAs is expected to bolster opportunities for Indian exporters in developed markets through its nine new FTAs with ...
Motilal Oswal raises mid and smallcap allocation to 50%, stays neutral on Indian equitiesMotilal Oswal Private Wealth favors Indian mid and small-cap stocks. They are increasing allocations to these segments by ten percentage po...
Kazakhstan eyes stronger trade ties with West BengalKazakhstan's ambassador expressed keen interest in expanding business engagement with West Bengal. The nation views West Bengal as a crucia...
Pharma mutual funds top return charts across horizons. Should investors chase the rally or stay cautious?Pharma mutual funds are leading returns in CY2026, driven by strong earnings, defensive demand, and US export growth. Despite recent outper...
US tariff proposal wake-up call for Indian pharma to diversify, innovate: ExpertsUS pharma tariffs: Experts have urged a shift towards global diversification and prioritising innovation for Indian pharma to lessen market...
Parliament watch: FTA exports rise, PLI payouts growIndia's merchandise exports to its free trade agreement (FTA) partner countries rose 25% year-on-year to $43.14 billion in the April-June q...
Govt disburses Rs 35,354 crore as on March 31 under PLI schemes: Jitin PrasadaProduction Linked Incentive schemes, which aim to boost manufacturing and attract significant investments, have disbursed Rs 35,354 crore t...
Pharma deal activity hits four-quarter low, but mega Sun Pharma acquisition drives valueIndia's pharma and healthcare sector recorded 65 deals worth $13.9 billion in Q2 CY2026, with volumes falling 17% quarter-on-quarter to a f...
Tariffs alone will not produce sustainable generic medicine in US: IPAThe Indian Pharmaceutical Alliance believes tariffs alone will not build US generic drug manufacturing. Broader reforms are needed for fair...